Sign up online today & collaborate
or click here to find out more
The antibiotics market is at risk of losing another decade to inadequate levels of research and innovation in favour of rare disease drugs, according to a new study.
A report from intellectual property firm Marks & Clarke looked at patent trends over the last decade and found that less than 5% of antibiotic patents filed since 2004 were for new classes of drugs in this area.For more click here
Source: Pharma Times